Table I.
Baseline clinicopathological characteristics of the cases obtained from TCGA.
| Characteristics | N (%) |
|---|---|
| Age, years | |
| <60 | 124 (27.0) |
| ≥60 | 332 (72.2) |
| Sex | |
| Female | 216 (47.2) |
| Male | 242 (52.8) |
| Stage | |
| I | 76 (17.0) |
| II | 178 (39.7) |
| III | 129 (28.8) |
| IV | 65 (14.5) |
| T stage | |
| T1 | 11 (2.4) |
| T2 | 78 (17.0) |
| T3 | 312 (68.1) |
| T4 | 56 (12.2) |
| Tis | 1 (0.2) |
| N stage | |
| N0 | 269 (58.7) |
| N1/2 | 189 (41.2) |
| M Stage | |
| M0 | 336 (83.8) |
| M1 | 65 (16.2) |
| Radiation therapy | |
| No | 379 (97.7) |
| Yes | 9 (2.3) |
| Residual tumor | |
| R0 | 330 (85.7) |
| R1 | 4 (1.0) |
| R2 | 26 (6.8) |
| RX | 25 (6.5) |
| Histological type | |
| Adenocarcinoma | 391 (86.3) |
| Mucinous adenocarcinoma | 62 (13.7) |
| Ethnicity | |
| American Indiana or Alaskan native | 1 (0.4) |
| Asian | 11 (3.9) |
| Black or African American | 59 (20.8) |
| White | 213 (75.0) |
a
As described in TCGA. TCGA, The Cancer Genome Atlas.